Relay Therapeutics (RLAY) P/E (2020 - 2026)
Relay Therapeutics (RLAY) P/E from Sep 30, 2020 to Jul 21, 2026. The TTM Relay Therapeutics (RLAY) P/E is -12.51. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Relay Therapeutics (RLAY)
| Year | P/E | Change |
|---|---|---|
| 2026 | -12.51 | +137.70% |
| 2025 | -5.26 | +192.31% |
| 2024 | -1.80 | -56.25% |
| 2023 | -4.12 | -28.41% |
| 2022 | -5.75 | -28.19% |
| 2021 | -8.01 | -99.82% |
| 2020 | -4.44K | N/A |
Comparison Relay Therapeutics (RLAY) P/E with competitors
Relay Therapeutics (RLAY) P/E is -12.51.